Incidence
In Hungary, the estimated incidence rate for prostate cancer is 133.2 per 100,000 population.1 With the European average of estimated prostate cancer incidence being 153.9 per 100,000, the incidence rate in Hungary is lower than the EU average.1
133.2
Hungary, new cases per 100,000, 20201
153.9
EU27 average, new cases per 100,000, 20201
(crude rate per 100,000 population)
Mortality
In Hungary, the estimated mortality for prostate cancer is 31.6 per 100,000.1 Mortality in Hungary is therefore lower than the EU27 average of 32.1 per 100,000.1
31.6
Hungary, deaths per 100,000, 20201
32.1
EU27 average, deaths per 100,000, 20201
(crude rate per 100,000 population)
Survival
There is no up-to-date data available on average five-year survival rates for prostate cancer in Hungary, indicating the need for better outcome data collection for people affected by prostate cancer.
National policies
In 2006, Hungary issued the National Cancer Control Programme. The increasing number of prostate cancers is mentioned as one of the causes of higher incidence of cancer within the male population in Hungary. A healthy diet is listed as a prevention method for prostate cancer. Hungarian authorities are currently developing a new cancer plan with the objective of improving patients’ survival and quality of life. In addition, a tax-benefit package has been introduced for patients suffering from prostate cancer.1
Clinical guidelines
Hungary follows the indications contained in the Guideline for the treatment of prostate cancer (2008). The recommended care pathway includes patient access to*:
- Included
- Not included
- Included
- Included
- Included
- Not included
- Not included
Cancer care
Access to specialists
There is approximately one urologist per 39,624 inhabitants in Hungary.1,2 Compared to the EU average, Hungary has fewer doctors (3.3 vs. 3.6 per 1,000 population). Workforce shortages have been exacerbated by an ageing health workforce and the emigration of many doctors (particularly specialists), which accelerated after the country’s accession to the EU in 2004.3
Cost of cancer
In Hungary, the direct cost of cancer care and treatment per person is €63,1 which is considerably lower than the European average of €154 per person.2 In fact, Hungary spends much less on health than the EU average, both in absolute terms and as a share of GDP.3
Cancer medicines spend
€40 is spent on cancer medicines per capita in Hungary.1 In 2018, cancer medicines accounted for more than half of the direct costs in Hungary, along with Croatia, Spain and Bulgaria.1 The question of access to medicines has gained attention in recent years. The government has taken action to engage in regional collaborations to improve equal access to medicines.2
Organisations
Patient organisations
The main cancer patient organisation in Hungary is:
Hungarian League Against Cancer
https://www.rakliga.hu/
References
Links to external websites are provided as a resource to the viewer. We accept no responsibility for the content or services of the linked site other than the information or other materials provided or reviewed by the LTPC expert group members
Incidence
1 European Cancer Information System (ECIS). Estimates of cancer incidence and mortality in 2020. Accessible at https://ecis.jrc.ec.europa.eu/explorer.php?$0-0$1-All$2-All$4-1$3-34$6-0,85$5-2008,2008$7-7$CEstByCountry$X0_8-3$X0_19-AE27$X0_20-No$CEstBySexByCountry$X1_8-3$X1_19-AE27$X1_-1-1$CEstByIndiByCountry$X2_8-3$X2_19-AE27$X2_20-No$CEstRelative$X3_8-3$X3_9-AE27$X3_19-AE27$CEstByCountryTable$X4_19-AE27 (last accessed February 2022
Chart source
European Cancer Information System (ECIS). Estimates of cancer incidence and mortality in 2020. Accessible at https://ecis.jrc.ec.europa.eu/explorer.php?$0-0$1-All$2-All$4-1$3-34$6-0,85$5-2008,2008$7-8$CEstByCountry$X0_8-3$X0_19-AE27$X0_20-No$CEstBySexByCountry$X1_8-3$X1_19-AE27$X1_-1-1$CEstByIndiByCountry$X2_8-3$X2_19-AE27$X2_20-No$CEstRelative$X3_8-3$X3_9-AE27$X3_19-AE27$CEstByCountryTable$X4_19-AE27 (last accessed March 2022)
Mortality
1 European Cancer Information System (ECIS). Estimates of cancer incidence and mortality in 2020. Accessible at https://ecis.jrc.ec.europa.eu/explorer.php?$0-0$1-All$2-All$4-1$3-34$6-0,85$5-2008,2008$7-8$CEstByCountry$X0_8-3$X0_19-AE27$X0_20-No$CEstBySexByCountry$X1_8-3$X1_19-AE27$X1_-1-1$CEstByIndiByCountry$X2_8-3$X2_19-AE27$X2_20-No$CEstRelative$X3_8-3$X3_9-AE27$X3_19-AE27$CEstByCountryTable$X4_19-AE27 (last accessed February 2022)
Chart source
European Cancer Information System (ECIS). Estimates of cancer incidence and mortality in 2020. Accessible at https://ecis.jrc.ec.europa.eu/explorer.php?$0-0$1-All$2-All$4-1$3-34$6-0,85$5-2008,2008$7-8$CEstByCountry$X0_8-3$X0_19-AE27$X0_20-No$CEstBySexByCountry$X1_8-3$X1_19-AE27$X1_-1-1$CEstByIndiByCountry$X2_8-3$X2_19-AE27$X2_20-No$CEstRelative$X3_8-3$X3_9-AE27$X3_19-AE27$CEstByCountryTable$X4_19-AE27 (last accessed March 2022)
Survival
Chart source
Hofmarcher, T et al. Comparator Report on Cancer in Europe in 2019. IHE Report 2019:7. Accessible at https://www.efpia.eu/publications/cancer-comparator-report/cancer-types/prostate-cancer/ (last accessed March 2022)
Cancer care
Access to specialists
1 Boszormenyi-Nagy, G. Beszámoló az urológiai fekvőbeteg-ellátásról a 2018-as adatok alapján. Magyar Urologia. 2020. 26-27
2 United Nations, Population Division, Department of Economic and Social Affairs. World Population Prospects 2019. Accessible at https://population.un.org/wpp/Download/Files/1_Indicators%20(Standard)/
EXCEL_FILES/1_Population/WPP2019_POP_F01_1_TOTAL_POPULATION_BOTH_SEXES.xlsx (last accessed March 2022)
3 European Commission and OECD. State of Health in the EU – Hungary Country Health Profile 2019. Accessible at https://read.oecd-ilibrary.org/social-issues-migration-health/hungary-country-health-profile-2019_4b7ba48c-en#page1 (last accessed March 2022)
Cost of cancer
1 Hofmarcher, T et al. Comparator Report on Cancer in Europe in 2019. IHE Report 2019:7. Accessible at https://www.efpia.eu/publications/cancer-comparator-report/cancer-types/prostate-cancer/ (last accessed March 2022)
2 Hofmarcher, T et al. Comparator Report on Cancer in Europe in 2019. IHE Report 2019:7. Accessible at https://www.efpia.eu/publications/cancer-comparator-report/cancer-types/prostate-cancer/ (last accessed March 2022) – average calculated from data included for individual countries.
3 European Commission and OECD. State of Health in the EU – Hungary Country Health Profile 2019. Accessible at https://ec.europa.eu/health/sites/health/files/state/docs/2019_chp_hu_english.pdf (last accessed March 2022)
Cancer medicines spend
1 Hofmarcher, T et al. Comparator Report on Cancer in Europe in 2019. IHE Report 2019:7. Accessible at https://www.efpia.eu/publications/cancer-comparator-report/cancer-types/prostate-cancer/ (last accessed March 2022)
2 European Commission and OECD. State of Health in the EU – Hungary Country Health Profile 2019. Accessible at https://ec.europa.eu/health/sites/health/files/state/docs/2019_chp_hu_english.pdf (last accessed March 2022)
Chart sources
*Different data sources were used for Belgium, Hungary, Italy, Romania and the UK, which may use data from different years. See references below. No data was found for Cyprus, Luxembourg, Malta and Slovakia.
European Society of Residents in Urology (ESRU). Countries. March 2018. Accessible at https://esru.eu/?q=countries (last accessed March 2022)
Federal Public Service of Public Health, Safety of the Food Chain and the Environment. HWF STATAN 2019 (detailed statistics). 2019. Accessible at https://organesdeconcertation.sante.belgique.be/fr/documents/hwf-statan-2019-statistiques-detaillees (last accessed March 2022)
Boszormenyi-Nagy, G. Report on urological inpatient care based on 2018 data. Urologia Hungarica. Accessible at http://urologiahungarica.hu/index.php/2020/05/12/beszamolo-az-urologiai-fekvobeteg-ellatasrol-a-2018-as-adatok-alapjan/ (last accessed March 2022)
I.Stat. Personale sanitario. Accessible at http://dati.istat.it/Index.aspx?DataSetCode=DCIS_PERS_SANIT (last accessed March 2022)
Institutul National De Statistica. Activitatea Unitatilor Sanitare in Anul 2019. 2020. Accessible at https://insse.ro/cms/sites/default/files/field/publicatii/activitatea_unitatilor_sanitare_anul_2019.pdf (last accessed March 2022)
United Nations, Population Division, Department of Economic and Social Affairs. World Population Prospects 2019. Accessible at https://population.un.org/wpp/Download/Files/1_Indicators%20(Standard)/EXCEL_FILES/1_Population/
WPP2019_POP_F01_1_TOTAL_POPULATION_BOTH_SEXES.xlsx (last accessed March 2022)
British Association of Urological Surgeons and The Specialist Advisory Committee in Urology. Workforce Report. 2018. Accessible at https://www.baus.org.uk/_userfiles/pages/files/publications/
Workforce_Report_Sep%202018%20ver%201.1.pdf (last accessed March 2022)
Hofmarcher, T et al. Comparator Report on Cancer in Europe in 2019. IHE Report 2019:7. Accessible at https://www.efpia.eu/publications/cancer-comparator-report/cancer-types/prostate-cancer/ (last accessed March 2022)
Hofmarcher, T et al. Comparator Report on Cancer in Europe in 2019. IHE Report 2019:7. Accessible at https://www.efpia.eu/publications/cancer-comparator-report/cancer-types/prostate-cancer/ (last accessed March 2022)
National policies
1 European Commission and OECD. State of Health in the EU – Hungary Country Health Profile 2019. Accessible at https://ec.europa.eu/health/sites/health/files/state/docs/2019_chp_hu_english.pdf (last accessed October 2023)